Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Oramed Pharmaceuticals Inc banner

Oramed Pharmaceuticals Inc
NASDAQ:ORMP

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Watchlist
Price: 3.25 USD -3.85% Market Closed
Market Cap: $129.4m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
+66%
5Y
+15%
10Y
-114%
Investing Cash Flow
+
3Y
-
5Y
+387%
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-
10Y
-

Cash Flow Statement
Oramed Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Aug-2005 Nov-2005 Feb-2006 May-2006 Aug-2006 Nov-2006 Feb-2007 May-2007 Aug-2007 Nov-2007 Feb-2008 May-2008 Aug-2008 Nov-2008 Feb-2009 May-2009 Aug-2009 Nov-2009 Feb-2010 May-2010 Aug-2010 Nov-2010 Feb-2011 May-2011 Aug-2011 Nov-2011 Feb-2012 May-2012 Aug-2012 Nov-2012 Feb-2013 May-2013 Aug-2013 Nov-2013 Feb-2014 May-2014 Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(3)
(4)
(4)
(4)
(3)
(4)
(4)
(4)
(3)
(2)
(2)
(2)
(3)
(3)
(3)
(2)
(2)
(1)
(2)
(3)
(3)
(4)
(4)
(5)
(4)
(4)
(4)
(5)
(6)
(6)
(7)
(7)
(7)
(8)
(8)
(8)
(11)
(11)
(13)
(13)
(10)
(10)
(10)
(13)
(13)
(15)
(15)
(15)
(14)
(13)
(13)
(11)
(12)
(15)
(15)
(19)
(23)
(12)
(36)
(41)
(41)
(38)
(31)
(21)
(17)
5
10
21
4
(19)
(28)
(24)
44
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
2
2
2
2
1
1
1
1
1
1
0
1
1
1
1
1
1
0
0
0
0
0
1
1
1
1
1
1
1
2
2
1
1
1
1
1
1
0
1
1
2
2
2
2
2
1
1
1
1
1
1
1
0
1
1
1
3
2
8
9
11
12
6
6
4
4
5
5
4
4
5
3
5
Other Non-Cash Items
0
0
0
0
0
0
0
0
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
(0)
(0)
(0)
(0)
1
1
1
1
1
1
1
1
1
1
2
2
2
1
1
1
1
1
0
1
1
2
2
2
3
2
1
1
1
1
2
1
2
2
2
2
3
3
2
8
9
10
11
6
5
4
(13)
(14)
(25)
(15)
7
15
11
(60)
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
(3)
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
3
3
2
2
0
0
Change in Working Capital
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(1)
0
0
0
0
(0)
0
0
(0)
0
(0)
(1)
(0)
(0)
0
0
0
0
0
0
1
1
1
5
4
15
19
15
15
3
(2)
(3)
(2)
(4)
(3)
(0)
(1)
0
(1)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
(1)
(4)
(2)
(0)
(1)
0
(3)
(4)
(3)
(3)
3
3
3
2
(3)
5
Cash from Operating Activities
(0)
N/A
(0)
-25%
(0)
N/A
(0)
-160%
(0)
-177%
(0)
-25%
(1)
-16%
(1)
-25%
(1)
+8%
(1)
-55%
(1)
-20%
(1)
-25%
(2)
-31%
(2)
-35%
(3)
-9%
(2)
+11%
(2)
+5%
(1)
+40%
(1)
+4%
(2)
-21%
(1)
+10%
(2)
-23%
(2)
+13%
(2)
-6%
(2)
-6%
(2)
+1%
(2)
-24%
(2)
-14%
(2)
+4%
(3)
-13%
(3)
-26%
(3)
-5%
(3)
+2%
(3)
+1%
(4)
-6%
(4)
+0%
(4)
-15%
(5)
-16%
(5)
-3%
(5)
+2%
(5)
-5%
(6)
-17%
(2)
+68%
(3)
-70%
5
N/A
8
+80%
3
-63%
3
-4%
(6)
N/A
(10)
-73%
(11)
-5%
(12)
-14%
(15)
-22%
(16)
-10%
(14)
+10%
(14)
+1%
(13)
+10%
(12)
+9%
(14)
-15%
(13)
+2%
(12)
+6%
(16)
-25%
(15)
+2%
(18)
-15%
(21)
-21%
(11)
+47%
(32)
-188%
(35)
-9%
(31)
+11%
(28)
+10%
(24)
+13%
(18)
+24%
(17)
+8%
(10)
+39%
(6)
+40%
(2)
+76%
(8)
-423%
(8)
-6%
(10)
-24%
(16)
-54%
(11)
+34%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(3)
(2)
(0)
(0)
2
0
(1)
(0)
1
1
(0)
(1)
(2)
(1)
1
2
2
2
(1)
(2)
(5)
(5)
(16)
(16)
(13)
(11)
(2)
1
(3)
(4)
(13)
(14)
(16)
(20)
(5)
(5)
4
3
5
7
(7)
1
(2)
(2)
11
11
14
(4)
5
3
(4)
17
(23)
(99)
(113)
(110)
(80)
31
10
(15)
(91)
(73)
(30)
80
120
106
99
(50)
23
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(0)
-100%
(0)
-350%
(0)
-22%
(3)
-2 482%
(2)
+36%
(0)
+98%
(0)
+50%
2
N/A
0
-81%
(1)
N/A
(1)
+64%
1
N/A
1
+56%
(0)
N/A
(1)
-239%
(2)
-32%
(1)
+21%
1
N/A
2
+25%
2
+2%
2
N/A
(1)
N/A
(2)
-17%
(5)
-182%
(5)
-13%
(16)
-211%
(16)
N/A
(13)
+19%
(11)
+13%
(2)
+80%
1
N/A
(3)
N/A
(4)
-20%
(13)
-222%
(14)
-11%
(16)
-13%
(20)
-27%
(5)
+73%
(5)
+7%
4
N/A
3
-40%
5
+105%
7
+24%
(7)
N/A
1
N/A
(2)
N/A
(2)
+12%
11
N/A
11
-2%
14
+24%
(4)
N/A
5
N/A
3
-35%
(4)
N/A
16
N/A
(24)
N/A
(99)
-318%
(114)
-14%
(111)
+3%
(80)
+27%
30
N/A
10
-68%
(15)
N/A
(92)
-495%
(73)
+20%
(30)
+59%
80
N/A
120
+51%
106
-12%
99
-6%
(50)
N/A
23
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
1
1
1
1
2
2
2
3
5
5
5
3
0
0
0
0
0
0
3
4
4
3
1
0
3
5
5
5
6
4
21
21
17
21
5
5
10
5
17
17
12
12
0
0
2
6
7
7
23
17
17
16
0
0
2
22
24
24
47
49
101
61
139
117
68
12
11
11
7
2
(0)
0
(1)
(2)
0
(3)
(2)
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75
50
31
0
(75)
(50)
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
1
(1)
(1)
(0)
(0)
0
0
0
0
0
(0)
0
0
0
Cash from Financing Activities
0
N/A
0
+25%
0
N/A
0
+540%
1
+69%
1
-2%
1
+25%
1
+117%
2
+64%
2
N/A
2
-6%
3
+44%
5
+57%
5
N/A
5
N/A
3
-41%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
3
+937%
4
+19%
4
N/A
3
-8%
1
-83%
0
N/A
3
N/A
5
+42%
5
0%
5
N/A
6
+18%
4
-25%
21
+378%
21
+1%
17
-21%
21
+29%
5
-77%
5
-3%
10
+101%
5
-48%
17
+232%
17
+0%
12
-28%
12
+1%
0
-96%
0
-10%
2
+270%
6
+304%
7
+11%
7
+4%
23
+205%
17
-23%
17
-4%
16
-2%
0
N/A
0
N/A
2
+23 200%
22
+858%
24
+7%
24
+2%
47
+95%
49
+4%
103
+108%
61
-41%
140
+131%
118
-16%
67
-43%
11
-84%
11
+1%
11
N/A
81
+643%
52
-36%
31
-41%
(0)
N/A
(76)
-3 792 050%
(52)
+31%
0
N/A
(3)
N/A
(2)
+33%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
(0)
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
0
Net Change in Cash
0
N/A
0
N/A
0
N/A
0
N/A
0
-5%
0
-56%
0
+75%
1
+457%
2
+123%
1
-20%
1
-28%
2
+67%
0
-79%
1
+106%
2
+218%
1
-76%
(1)
N/A
(1)
-91%
(3)
-158%
(2)
+23%
(1)
+75%
(0)
+90%
1
N/A
1
-35%
0
-60%
0
+29%
(0)
N/A
(1)
-491%
3
N/A
4
+37%
0
-95%
(0)
N/A
(2)
-985%
(4)
-92%
1
N/A
1
+12%
(1)
N/A
5
N/A
(2)
N/A
1
N/A
1
+6%
(5)
N/A
2
N/A
(1)
N/A
1
N/A
0
-50%
(2)
N/A
(2)
+12%
0
N/A
(1)
N/A
2
N/A
2
+4%
1
-47%
3
+156%
0
-95%
0
+125%
(2)
N/A
(1)
+58%
3
N/A
5
+114%
16
+198%
12
-26%
28
+137%
48
+73%
58
+20%
(50)
N/A
(6)
+88%
(28)
-371%
(44)
-60%
13
N/A
(4)
N/A
(23)
-500%
(28)
-20%
(31)
-13%
(6)
+82%
78
N/A
37
-53%
45
+24%
56
+23%
(69)
N/A
10
N/A
Free Cash Flow
Free Cash Flow
(0)
N/A
(0)
-25%
(0)
N/A
(0)
-160%
(0)
-177%
(0)
-25%
(1)
-16%
(1)
-25%
(1)
+8%
(1)
-57%
(1)
-28%
(2)
-25%
(2)
-30%
(3)
-32%
(3)
-6%
(2)
+12%
(2)
+5%
(1)
+39%
(1)
+4%
(2)
-20%
(1)
+11%
(2)
-23%
(2)
+13%
(2)
-6%
(2)
-6%
(2)
+1%
(2)
-24%
(2)
-14%
(2)
+4%
(3)
-13%
(3)
-26%
(3)
-5%
(3)
+1%
(3)
+1%
(4)
-6%
(4)
+0%
(4)
-14%
(5)
-16%
(5)
-2%
(5)
+2%
(5)
-5%
(6)
-17%
(2)
+68%
(3)
-71%
5
N/A
8
+81%
3
-63%
3
-4%
(6)
N/A
(10)
-72%
(11)
-5%
(12)
-14%
(15)
-22%
(16)
-10%
(15)
+10%
(14)
+1%
(13)
+10%
(12)
+9%
(14)
-15%
(13)
+2%
(13)
+6%
(16)
-28%
(16)
+2%
(18)
-15%
(22)
-20%
(11)
+48%
(32)
-189%
(35)
-9%
(31)
+11%
(28)
+9%
(25)
+12%
(19)
+23%
(18)
+9%
(11)
+40%
(6)
+40%
(2)
+75%
(8)
-411%
(8)
-6%
(10)
-24%
(16)
-54%
(11)
+34%

See Also

Summary
ORMP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORMP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORMP stock valuation using valuation multiples.
Wall Street Estimates
ORMP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORMP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.